Non-proliferative diabetic retinopathy (NPDR)

Clinical trials for Non-proliferative diabetic retinopathy (NPDR) explained in plain language.

Never miss a new study

Get alerted when new Non-proliferative diabetic retinopathy (NPDR) trials appear

Sign up with your email to follow new studies for Non-proliferative diabetic retinopathy (NPDR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 2 Not yet finished but already full! 1

New eye drops aim to boost blood flow in diabetic retinopathy and glaucoma

Disease control Ongoing

This early study tests whether QLS-111 eye drops can improve blood flow to the back of the eye in people with non-proliferative diabetic retinopathy or certain types of glaucoma. Fourteen participants will use the drops twice daily for two weeks. The main goal is to measure chang…

Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)

Phase 2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC

Non-proliferative diabetic retinopathy (NPDR)

Get alerted when new Non-proliferative diabetic retinopathy (NPDR) trials appear

New eye drops aim to boost blood flow in diabetic retinopathy and glaucoma